
Please try another search
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China. The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine. It also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Name | Age | Since | Title |
---|---|---|---|
Yuancheng Lou | 40 | 2020 | Supervisory Board Chairman |
Bei Fan | 52 | 2020 | Non-Independent Director |
Wenqi An | 45 | 2020 | Non-Independent Director |
Wenjue An | 35 | 2022 | GM & Director |
Yang Dong Sheng | 60 | 2020 | Independent Director |
Xiaowei Ma | 56 | 2020 | Non-Independent Director |
Kang An | 75 | 2020 | Non-Independent Chairman |
Dexin Li | 71 | 2020 | Independent Director |
Chaoyuan Ma | 41 | 2020 | Non-Employee Supervisor |
Ruowen Pan | 57 | 2020 | Executive VP & Director |
Xinlei Hu | 36 | 2023 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review